tiprankstipranks
Clinigence Holdings Inc (NUTX)
NASDAQ:NUTX
US Market
NUTX
Clinigence Holdings
RESEARCH TOOLSreports
Want to see NUTX full AI Analyst Report?

Clinigence Holdings (NUTX) Ratios

393 Followers

Clinigence Holdings Ratios

NUTX's free cash flow for Q1 2026 was $0.42. For the 2026 fiscal year, NUTX's free cash flow was decreased by $ and operating cash flow was $0.38. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Mar 25Dec 23Dec 22
Liquidity Ratios
Current Ratio
 3.14 3.41 2.08 1.56 1.79
Quick Ratio
 3.12 3.39 2.06 1.50 1.72
Cash Ratio
 1.12 1.18 0.31 0.38 0.62
Solvency Ratio
 0.23 0.18 0.16 -0.09 -1.32
Operating Cash Flow Ratio
 1.48 1.57 0.16 0.02 0.92
Short-Term Operating Cash Flow Coverage
 16.16 17.63 1.29 0.09 3.34
Net Current Asset Value
$ 64.38M$ 43.72M$ -160.95M$ -228.29M$ -213.45M
Leverage Ratios
Debt-to-Assets Ratio
 0.36 0.38 0.52 0.69 0.62
Debt-to-Equity Ratio
 1.01 1.07 2.33 4.49 2.79
Debt-to-Capital Ratio
 0.50 0.52 0.70 0.82 0.74
Long-Term Debt-to-Capital Ratio
 0.07 0.08 0.13 0.30 0.19
Financial Leverage Ratio
 2.76 2.79 4.48 6.48 4.50
Debt Service Coverage Ratio
 6.22 6.15 3.54 -0.31 -14.72
Interest Coverage Ratio
 13.29 12.40 6.55 -1.95 -32.55
Debt to Market Cap
 0.06 0.04 0.25 0.34 0.03
Interest Debt Per Share
 55.19 58.73 70.63 66.26 66.17
Net Debt to EBITDA
 0.49 0.58 2.00 -17.40 -0.59
Profitability Margins
Gross Profit Margin
47.47%50.76%40.89%14.04%7.03%
EBIT Margin
30.79%30.51%27.02%-12.99%-185.67%
EBITDA Margin
33.17%32.85%30.97%-5.89%-179.68%
Operating Profit Margin
31.39%31.49%27.22%-12.83%-185.41%
Pretax Profit Margin
28.42%27.97%22.87%-19.58%-191.36%
Net Profit Margin
10.95%8.09%10.87%-18.49%-193.70%
Continuous Operations Profit Margin
21.86%20.61%19.85%-17.53%-197.33%
Net Income Per EBT
38.53%28.92%47.54%94.42%101.22%
EBT Per EBIT
90.55%88.81%84.02%152.61%103.21%
Return on Assets (ROA)
10.07%7.71%7.96%-11.50%-98.39%
Return on Equity (ROE)
31.39%21.49%35.65%-74.51%-443.11%
Return on Capital Employed (ROCE)
35.74%36.24%25.39%-9.35%-107.88%
Return on Invested Capital (ROIC)
26.57%25.91%20.91%-7.90%-102.17%
Return on Tangible Assets
10.45%8.01%8.34%-12.69%-107.94%
Earnings Yield
11.83%6.76%32.29%-38.47%-35.26%
Efficiency Ratios
Receivables Turnover
 2.59 2.69 2.03 3.94 3.76
Payables Turnover
 9.95 8.80 20.32 8.42 8.52
Inventory Turnover
 98.80 150.38 99.55 62.78 57.70
Fixed Asset Turnover
 2.57 2.55 1.48 0.92 0.74
Asset Turnover
 0.92 0.95 0.73 0.62 0.51
Working Capital Turnover Ratio
 2.27 3.29 5.21 6.55 2.75
Cash Conversion Cycle
 107.87 96.66 165.22 54.99 60.55
Days of Sales Outstanding
 140.85 135.71 179.52 92.52 97.06
Days of Inventory Outstanding
 3.69 2.43 3.67 5.81 6.33
Days of Payables Outstanding
 36.68 41.47 17.96 43.35 42.84
Operating Cycle
 144.54 138.13 183.18 98.34 103.39
Cash Flow Ratios
Operating Cash Flow Per Share
 40.69 39.00 4.54 0.29 11.97
Free Cash Flow Per Share
 40.14 38.61 4.09 -1.87 8.51
CapEx Per Share
 0.55 0.40 0.45 2.15 3.46
Free Cash Flow to Operating Cash Flow
 0.99 0.99 0.90 -6.56 0.71
Dividend Paid and CapEx Coverage Ratio
 7.09 98.23 2.65 0.09 0.77
Capital Expenditure Coverage Ratio
 74.44 98.23 10.05 0.13 3.46
Operating Cash Flow Coverage Ratio
 0.78 0.71 0.07 <0.01 0.19
Operating Cash Flow to Sales Ratio
 0.31 0.28 0.05 <0.01 0.23
Free Cash Flow Yield
37.17%23.45%12.90%-6.92%2.99%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 8.45 14.79 3.10 -2.60 -2.84
Price-to-Sales (P/S) Ratio
 0.82 1.20 0.34 0.48 5.49
Price-to-Book (P/B) Ratio
 2.35 3.18 1.10 1.94 12.57
Price-to-Free Cash Flow (P/FCF) Ratio
 2.69 4.26 7.75 -14.44 33.48
Price-to-Operating Cash Flow Ratio
 2.99 4.22 6.98 94.73 23.80
Price-to-Earnings Growth (PEG) Ratio
 1.43 1.68 -0.02 0.03 <0.01
Price-to-Fair Value
 2.35 3.18 1.10 1.94 12.57
Enterprise Value Multiple
 2.96 4.22 3.08 -25.57 -3.65
Enterprise Value
 865.43M 1.21B 458.34M 372.78M 1.44B
EV to EBITDA
 2.96 4.22 3.08 -25.57 -3.65
EV to Sales
 0.98 1.39 0.95 1.51 6.56
EV to Free Cash Flow
 3.22 4.94 21.98 -45.24 39.96
EV to Operating Cash Flow
 3.17 4.89 19.80 296.69 28.41
Tangible Book Value Per Share
 60.77 61.04 33.81 9.42 19.43
Shareholders’ Equity Per Share
 51.68 51.79 28.69 13.94 22.68
Tax and Other Ratios
Effective Tax Rate
 0.23 0.26 0.13 0.10 -0.03
Revenue Per Share
 131.31 137.59 94.11 56.18 51.88
Net Income Per Share
 14.38 11.13 10.23 -10.39 -100.50
Tax Burden
 0.39 0.29 0.48 0.94 1.01
Interest Burden
 0.92 0.92 0.85 1.51 1.03
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
 0.06 0.19 0.12 0.13 0.09
Stock-Based Compensation to Revenue
 0.10 0.13 0.03 0.01 <0.01
Income Quality
 1.59 1.38 0.24 -0.03 -0.12
Currency in USD